InvestorsHub Logo
Followers 134
Posts 7040
Boards Moderated 0
Alias Born 02/09/2012

Re: None

Saturday, 03/08/2014 6:13:54 PM

Saturday, March 08, 2014 6:13:54 PM

Post# of 55001
For those who either doubt there would or should be a MJ play by XXII, because 1. Nothing was definitively said by the company, or 2. It would be a distraction to management.

I would make two observations: point one, we do not necessarily have to receive definitive word to speculate on the xxii technology " fitting " into MJ modification, because it clearly could and would. Clearly it would be a big boost to SP if they announced use of tech for medical MJ modification to remove carcinogens or other means to remove negative aspects of the MJ plant and to accentuate the positives. They would be foolish in not capitalizing on their patents in this area. IMO management has not shown itself to be foolish or short sighted regarding opportunities. For that reason alone I believe they will "lock-down" an extension of their patents to apply to MJ modification and do so with a specific focus in mind. They would be foolish not to!

That brings us to the second point. "Keeping focused and within the scope of what management are trying to achieve. "
I would bet most investors have not even gone to the XXII web site to learn that XXII is a plant tech HOLDING company. XXII has two missions: plant bio-research through Hercules pharma and distribution of the proprietary cigarette through its subsidiary Goodwich. Hercules has done extensive research. How did they do so much research with so few employees? They did so through contracts with third party research universities and labs. XXII's scientific staff only needs to consult with these third parties and put them into motion, then monitor results and outcome.

Bottom line it would be foolish not to negotiate (and annouce) patent extensions to MJ and utilize them, which IMHO would not be a significant drain on man power or focus.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent XXII News